Trexquant Investment LP Eiger Bio Pharmaceuticals, Inc. Transaction History

Trexquant Investment LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$3.84 - $9.74 $69,292 - $175,758	-18,045 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$5.12 - $8.19 $92,390 - $147,788	18,045 New	18,045 $94,000
Q3 2020 Nov 06, 2020	SELL	$7.96 - $12.42 $266,102 - $415,200	-33,430 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$5.4 - $13.37 $180,522 - $446,959	33,430 New	33,430 $321,000
Q1 2019 May 13, 2019	SELL	$10.31 - $14.38 $242,779 - $338,620	-23,548 Closed	0 $0

Q4 2018 Feb 13, 2019	BUY	$8.63 - $12.4 $203,219 - $291,995	23,548 New	23,548 $239,000

748K

Ticker EIGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,966,800
Market Cap $496M
Description
Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to ...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.